Find out about the latest Preferred Medical company news and take a look at our upcoming events. While you’re here, sign up to receive our email newsletter.
Summary For traditional generic drugs, the current pharmaceutical pipeline is drying up. In an article we published last November, we referenced that 65% of all new drug launches would be specialty drugs by the end of 2023. This is important as new generic drug conversion opportunities will diminish over the next few years. How does …
Read More
With advancements in science and technology in the past 30 years, a distinct trend has emerged in the pharmaceutical industry. Pharmaceutical manufacturers have expanded their pipelines to launch new ‘specialty’ drugs designed to treat rare, complex, chronic diseases like cancer, rheumatoid arthritis, and multiple sclerosis. What follows is an overview of the specialty drug market …
Read More